Growth Value Balance (P/E < 25) — Growth stock screen for NSE and BSE companies
Sales growth > 12%, net profit growth > 12%, ROCE > 14%, and P/E below 25 The screen evaluates growth criteria across quarterly consolidated filings and surfaces Price, Sales growth, Profit growth, ROCE for every matching company, alongside price, market capitalisation and valuation context.
Results are rebuilt from quarterly filings: anchor to a reporting period with the period control, switch between a focused metric view and the full column set, sort any column, and follow each symbol into its company page for statements, shareholding history and ratio analysis.
The methodology, column definitions and analysis guidelines on this page are free to read; the live results table is a JustTicks premium feature. Screening output is a research starting point — verify the underlying filings before acting, since a company can pass numerical filters while carrying risks the selected metrics never capture.
What does the Growth Value Balance (P/E < 25) screener identify?
Sales growth > 12%, net profit growth > 12%, ROCE > 14%, and P/E below 25 The screen ranks matching companies on Price, Sales growth, Profit growth, ROCE using quarterly consolidated filings, with every row linking to the company's full fundamentals workspace.
How often is the Growth Value Balance (P/E < 25) screener updated?
The underlying data refreshes with quarterly shareholding and fundamental filings. A reporting-period control lets you anchor results to the latest quarter or compare earlier windows, and the reporting basis is consolidated.
Is the Growth Value Balance (P/E < 25) screener free to use?
The methodology, metric definitions and analysis guide on this page are free to read. The live results table requires a JustTicks premium subscription — this screen is classified as a growth, medium-risk strategy.
Related JustTicks tools: All fundamental screeners, High Sales Growth (>20%), High Net Profit Growth (>25%), Growth with Reasonable Valuation
Growth Value Balance (P/E < 25)
Sales growth > 12%, net profit growth > 12%, ROCE > 14%, and P/E below 25
Checking subscription...
Understanding Growth Investing
Sales growth > 12%, net profit growth > 12%, ROCE > 14%, and P/E below 25 Results are rebuilt from quarterly consolidated filings for NSE and BSE listed companies, with a reporting-period control to anchor or compare windows.
Key analysis points
- Growth stocks reinvest earnings for expansion
- Sales growth drives long-term stock performance
- Profit growth confirms business model scalability
- High growth commands premium valuations
- Growth sustainability matters more than current rate
Analysis guidelines
- Look for consistent growth (>15% CAGR) over multiple years
- Growth should be profitable (check earnings, not just sales)
- High growth with low debt is ideal combination
- Industry tailwinds support company growth
- Growth slows as companies mature - adjust expectations
Pro tips
- Pay reasonable price for growth (PEG < 1.5)
- Focus on companies with durable competitive advantages
- Growth investing requires patience and higher risk tolerance
- Monitor growth quarterly - slowdowns are warning signs
Frequently asked questions
Frequently asked questions
What does the Growth Value Balance (P/E < 25) screener identify?
Sales growth > 12%, net profit growth > 12%, ROCE > 14%, and P/E below 25 The screen ranks matching companies on Price, Sales growth, Profit growth, ROCE using quarterly consolidated filings, with every row linking to the company's full fundamentals workspace.
How often is the Growth Value Balance (P/E < 25) screener updated?
The underlying data refreshes with quarterly shareholding and fundamental filings. A reporting-period control lets you anchor results to the latest quarter or compare earlier windows, and the reporting basis is consolidated.
Is the Growth Value Balance (P/E < 25) screener free to use?
The methodology, metric definitions and analysis guide on this page are free to read. The live results table requires a JustTicks premium subscription — this screen is classified as a growth, medium-risk strategy.
More Growth screeners
For educational and informational purposes only — not investment advice. Data from quarterly consolidated filings (NSE/BSE); verify against exchange disclosures before acting.